Photo by nci from unsplash
Hess et al. recently hypothesized that shifts in circulating progenitor cell populations may drive cardiovascular protection by SGLT-2 inhibitors in patients with type 2 diabetes. In this Letter, Fadini challenges that… Click to show full abstract
Hess et al. recently hypothesized that shifts in circulating progenitor cell populations may drive cardiovascular protection by SGLT-2 inhibitors in patients with type 2 diabetes. In this Letter, Fadini challenges that interpretation and discusses previous findings from an independent randomized placebo-controlled trial indicating that cardiovascular protection by SGLT-2 inhibitors may not directly involve circulating stem/progenitor cells.
Keywords:
progenitor cells;
circulating progenitor;
inhibitors circulating;
sglt inhibitors;
cells diabetes;
progenitor
Journal Title: Cell metabolism
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cell metabolism
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!